These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23230081)

  • 1. Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.
    Mousa SA; Shaqura M; Khalefa BI; Zöllner C; Schaad L; Schneider J; Shippenberg TS; Richter JF; Hellweg R; Shakibaei M; Schäfer M
    Diabetes; 2013 Apr; 62(4):1308-19. PubMed ID: 23230081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor.
    Shaqura M; Khalefa BI; Shakibaei M; Winkler J; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
    J Pain; 2013 Jul; 14(7):720-30. PubMed ID: 23623572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes.
    Mousa SA; Shaqura M; Winkler J; Khalefa BI; Al-Madol MA; Shakibaei M; Schulz S; Schäfer M
    Pain; 2016 Apr; 157(4):910-921. PubMed ID: 26713421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy.
    Shaqura M; Khalefa BI; Shakibaei M; Zöllner C; Al-Khrasani M; Fürst S; Schäfer M; Mousa SA
    Neuropharmacology; 2014 Oct; 85():142-50. PubMed ID: 24863039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain.
    Mousa SA; Cheppudira BP; Shaqura M; Fischer O; Hofmann J; Hellweg R; Schäfer M
    Brain; 2007 Feb; 130(Pt 2):502-13. PubMed ID: 17142830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
    Sun J; Chen SR; Chen H; Pan HL
    J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats.
    Zurek JR; Nadeson R; Goodchild CS
    Pain; 2001 Feb; 90(1-2):57-63. PubMed ID: 11166970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy.
    Deshpande D; Agarwal N; Fleming T; Gaveriaux-Ruff C; Klose CSN; Tappe-Theodor A; Kuner R; Nawroth P
    Nat Commun; 2021 Jan; 12(1):426. PubMed ID: 33462216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and μ-opioid receptors.
    Dong J; Zuo Z; Yan W; Liu W; Zheng Q; Liu X
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1141-1149. PubMed ID: 31079200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of μ-Opioid Receptors in Primary Sensory Neurons.
    Zhang Y; Chen SR; Laumet G; Chen H; Pan HL
    J Biol Chem; 2016 Apr; 291(16):8475-85. PubMed ID: 26917724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute antinociceptive effect of fish oil or its major compounds, eicosapentaenoic and docosahexaenoic acids on diabetic neuropathic pain depends on opioid system activation.
    Redivo DDB; Jesus CHA; Sotomaior BB; Gasparin AT; Cunha JM
    Behav Brain Res; 2019 Oct; 372():111992. PubMed ID: 31152745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide Promotes Morphine Efficacy and Prevents Morphine-Induced Tolerance in Rats with Diabetic Neuropathy.
    Zhao J; Wang H; Song T; Yang Y; Gu K; Ma P; Zhang Z; Shen L; Liu J; Wang W
    Neurochem Res; 2016 Dec; 41(12):3171-3180. PubMed ID: 27573481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
    Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
    Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accessibility of axonal G protein coupled mu-opioid receptors requires conceptual changes of axonal membrane targeting for pain modulation.
    Mousa SA; Shaqura M; Al-Madol M; Tafelski S; Khalefa BI; Shakibaei M; Schäfer M
    J Control Release; 2017 Dec; 268():352-363. PubMed ID: 29054370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between cannabinoid and opioid receptors in a mouse model of diabetic neuropathy.
    Toniolo EF; Gupta A; Franciosi AC; Gomes I; Devi LA; Dale CS
    Pain; 2022 Jul; 163(7):1414-1423. PubMed ID: 34724682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
    Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
    Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
    Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 Mitogen-activated protein kinase activation by nerve growth factor in primary sensory neurons upregulates μ-opioid receptors to enhance opioid responsiveness toward better pain control.
    Yamdeu RS; Shaqura M; Mousa SA; Schäfer M; Droese J
    Anesthesiology; 2011 Jan; 114(1):150-61. PubMed ID: 21169793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy.
    Hall KE; Liu J; Sima AA; Wiley JW
    J Neurophysiol; 2001 Aug; 86(2):760-70. PubMed ID: 11495948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
    Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
    J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.